 Patients who were hospitalized more than two days before their FN episode or required 10 days or more of hospitalization after recovering from fever and low absolute neutrophil count (ANC) were excluded  Only direct medical costs were considered, and all the cost data were adjusted into 2014 U.S. dollars  Univariate analysis and multiple linear regression were conducted to identify the factors associated with higher FN costs Four hundred and thirteen hospitalizations with FN were documented in 367 adult cancer patients, and thirty-nine patients (11%) experienced more than one episode of FN The most common primary cancer types were breast cancer (36.8%), lymphoma (21.5%), gastrointestinal cancer (10.6%), head and neck cancer (9.3%), and lung cancer (8.5%) ( Table 1) The mean total hospital cost and mean out-of-pocket cost per FN episode for all of the hospitalizations were US$5,244 (95% CI: US$4,758-5,730) and US$2,847 (95% CI: US$2,516-3,178), respectively.
 In Singapore, limited data have been reported on the economic burden of the management of FN on cancer patients  Primary objective: To describe the total hospital cost and the out-ofpocket cost (censored by the government subsidy) for patients with solid tumors and lymphoma who received inpatient FN management  Secondary objective: To identify any clinical factors associated with a higher economic burden  A secondary analysis of a prospective study was conducted at the National Cancer Centre Singapore (NCCS) in 2014  All of the adult cancer cases (aged 18 years and above) hospitalized due to FN from 2009 to 2012 were studied  Patients who were hospitalized more than two days before their FN episode or required 10 days or more of hospitalization after recovering from fever and low absolute neutrophil count (ANC) were excluded  Only direct medical costs were considered, and all the cost data were adjusted into 2014 U.S. dollars  Univariate analysis and multiple linear regression were conducted to identify the factors associated with higher FN costs Four hundred and thirteen hospitalizations with FN were documented in 367 adult cancer patients, and thirty-nine patients (11%) experienced more than one episode of FN The most common primary cancer types were breast cancer (36.8%), lymphoma (21.5%), gastrointestinal cancer (10.6%), head and neck cancer (9.3%), and lung cancer (8.5%) ( Table 1) The mean total hospital cost and mean out-of-pocket cost per FN episode for all of the hospitalizations were US$5,244 (95% CI: US$4,758-5,730) and US$2,847 (95% CI: US$2,516-3,178), respectively.
Lymphoma had the highest mean total hospital cost (US$7,847) as well as the highest out-of-pocket cost (US$4,222) ( Figure 1) The main cost components in the out-of-pocket cost were prescription charges (36%) and ward charges (18%) (Figure 2) Clinical factors associated with a higher total hospital cost were longer length of stay, longer time to recover the ANC, severe sepsis, and lymphoma as underlying cancer.
The economic burden of FN management in lymphoma cases was substantial compared with other solid tumors Factors associated with a higher FN management cost may be useful for developing appropriate strategies to reduce the economic burden of FN for cancer patients 
